Kinase inhibitors (KIs) are a class of anticancer drugs that inhibit activity of the enzymes protein kinases, which regulate crucial cellular processes and have a demonstrated role in human oncogenesis. Treatment of advanced forms of endocrine cancer which are not responsive to cytotoxic chemotherapies is challenging and use of KIs is gaining a growing role in this field.
Targeted therapy with kinase inhibitors in aggressive endocrine tumors / Marotta, Vincenzo; Franzese, Maria Domenica; Del Prete, Michela; Chiofalo, Maria Grazia; Ramundo, Valeria; Esposito, Raffaella; Marciello, Francesca; Pezzullo, Luciano; Carratù, Annachiara; Vitale, Mario; Colao, Annamaria; Faggiano, Antongiulio. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1744-7666. - 14:9(2013), pp. 1187-1203. [10.1517/14656566.2013.796931]
Targeted therapy with kinase inhibitors in aggressive endocrine tumors
Ramundo, Valeria;Faggiano, Antongiulio
2013
Abstract
Kinase inhibitors (KIs) are a class of anticancer drugs that inhibit activity of the enzymes protein kinases, which regulate crucial cellular processes and have a demonstrated role in human oncogenesis. Treatment of advanced forms of endocrine cancer which are not responsive to cytotoxic chemotherapies is challenging and use of KIs is gaining a growing role in this field.| File | Dimensione | Formato | |
|---|---|---|---|
|
Marotta_Targeted-therapy_2013.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
615.35 kB
Formato
Adobe PDF
|
615.35 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
